In a PAYGO world, this is $14 billion worth of savings just waiting there on the table. It’s good for consumers, taxpayers, and policy-makers to create a clear regulatory pathway to get generic biologics to market. Biologics are great products and need as much competition as possible to be affordable enough for consumers.

This entry was posted on Thursday, January 4th, 2007 at 5:16 pm and is filed under Politics, Healthcare .